A comparative clinical study of Tulasi and Barbari in management of stress.

A COMPARATIVE PHARMACOLOGICAL STUDY ON TULASI (Ocimum sanctum Linn) AND BARBARI (Ocimum basilicum Linn) FOR THE ANTIOXIDANT AND ADAPTOGENIC ACTIVITY IN THE MANAGEMENT OF STRESS

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2015/04/005669

Enrollment

100

Registered

2015-04-07

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- STRESS

Interventions

Intervention1: Tulasi(Ocimum sanctum): 3gm plant powder twice a day for 3 months Control Intervention1: Barbari(Ocimum basilicum): 3gm plant powder twice a day for 3 months

Eligibility

Inclusion criteria

Inclusion criteria: 1)Subjects suffering from stress 2)Subjects interested in treatment for stress. 3)Subjects age between 18-65 yrs

Exclusion criteria

Exclusion criteria: 1) subjects suffering from chronic disorders like cancer, CRF, Diabetes mellitus under only on insulin treatment, CVA 2) Patients under psychiatric treatment 3) Below age of 18 years and above age of 65 years

Design outcomes

Primary

Measure	Time frame
Stress relievingTimepoint: within 90 days	—

Secondary

Measure	Time frame
Improved quality of life, adoptogenic and antioxidant activityTimepoint: with in 90 days	—

Countries

India

Contacts

Public ContactDr Renu dixit

DR. BRKR GOVERNMENT AYURVEDIC MEDICAL COLLEGE

narasimhav90@gmail.com09440043721

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026